Empagliflozin as add-on to metformin plus sulfonylurea in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial.

Saved in:
Bibliographic Details
Title: Empagliflozin as add-on to metformin plus sulfonylurea in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial.
Authors: Häring, Hans-Ulrich (AUTHOR), Merker, Ludwig (AUTHOR), Seewaldt-Becker, Elke (AUTHOR), Weimer, Marc (AUTHOR), Meinicke, Thomas (AUTHOR), Woerle, Hans J (AUTHOR), Broedl, Uli C (AUTHOR), EMPA-REG METSU Trial Investigators (CORPORATE AUTHOR)
Source: Diabetes Care. Nov2013, Vol. 36 Issue 11, p3396-3404. 9p.
Database: Academic Search Ultimate
Description
ISSN:01495992
DOI:10.2337/dc12-2673